A new study published in the journal Gastroenterology and Hepatology suggests that patients suffering from inflammatory bowel disease (IBD) may benefit by restarting infliximab therapy after dropping out of the therapy previously. "Our findings suggest that starting infliximab after a history of prior therapy can be very beneficial to patients," said lead study author Filip Baert, MD, PhD, from the department of gastroenterology, University Hospitals Leuven in Belgium. ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment